ATE545341T1 - Gelierungszusammensetzungen und -verfahren - Google Patents

Gelierungszusammensetzungen und -verfahren

Info

Publication number
ATE545341T1
ATE545341T1 AT06840918T AT06840918T ATE545341T1 AT E545341 T1 ATE545341 T1 AT E545341T1 AT 06840918 T AT06840918 T AT 06840918T AT 06840918 T AT06840918 T AT 06840918T AT E545341 T1 ATE545341 T1 AT E545341T1
Authority
AT
Austria
Prior art keywords
composition
polysaccharide
gelation
stomach
controlled release
Prior art date
Application number
AT06840918T
Other languages
English (en)
Inventor
Johnathan Richardson
Peter Dettmar
Olav Gaserod
Trond Helgerud
Original Assignee
Fmc Biopolymer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Biopolymer As filed Critical Fmc Biopolymer As
Application granted granted Critical
Publication of ATE545341T1 publication Critical patent/ATE545341T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Colloid Chemistry (AREA)
AT06840918T 2005-10-05 2006-10-04 Gelierungszusammensetzungen und -verfahren ATE545341T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72386205P 2005-10-05 2005-10-05
PCT/EP2006/009614 WO2007039294A2 (en) 2005-10-05 2006-10-04 Gelling compositions and methods

Publications (1)

Publication Number Publication Date
ATE545341T1 true ATE545341T1 (de) 2012-03-15

Family

ID=37762661

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06840918T ATE545341T1 (de) 2005-10-05 2006-10-04 Gelierungszusammensetzungen und -verfahren

Country Status (8)

Country Link
US (1) US20070087038A1 (de)
EP (1) EP1931222B1 (de)
JP (1) JP5541865B2 (de)
CN (1) CN101631476B (de)
AT (1) ATE545341T1 (de)
ES (1) ES2379723T3 (de)
PL (1) PL1931222T3 (de)
WO (1) WO2007039294A2 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1659882A1 (de) * 2003-09-03 2006-05-31 Unilever N.V. Nahrungsmittelzusammensetzungen, die das sättigungsgefühl fördern
US8784336B2 (en) 2005-08-24 2014-07-22 C. R. Bard, Inc. Stylet apparatuses and methods of manufacture
US20070116822A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-potency sweetener composition with saponin and compositions sweetened therewith
US20070116831A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Dental Composition with High-Potency Sweetener
US20070116836A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US20070116825A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Confection with High-Potency Sweetener
EP1965667A2 (de) * 2005-11-23 2008-09-10 The Coca-Cola Company Synthetische süssmittelzusammensetzungen mit verbessertem zeitverlaufsprofil und/oder geschmacksprofil, verfahren zu ihrer formulierung und ihre verwendungen
JP2009541297A (ja) * 2006-06-21 2009-11-26 エフエムシー バイオポリマー エイエス 胃活性化食物繊維
EP2053931B1 (de) * 2006-08-24 2012-02-08 Unilever N.V. Flüssige, das völlegefühl verstärkende zusammensetzung
US7794407B2 (en) 2006-10-23 2010-09-14 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8388546B2 (en) 2006-10-23 2013-03-05 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US9521961B2 (en) 2007-11-26 2016-12-20 C. R. Bard, Inc. Systems and methods for guiding a medical instrument
US8849382B2 (en) 2007-11-26 2014-09-30 C. R. Bard, Inc. Apparatus and display methods relating to intravascular placement of a catheter
US9456766B2 (en) 2007-11-26 2016-10-04 C. R. Bard, Inc. Apparatus for use with needle insertion guidance system
US10524691B2 (en) 2007-11-26 2020-01-07 C. R. Bard, Inc. Needle assembly including an aligned magnetic element
US8781555B2 (en) 2007-11-26 2014-07-15 C. R. Bard, Inc. System for placement of a catheter including a signal-generating stylet
US9649048B2 (en) 2007-11-26 2017-05-16 C. R. Bard, Inc. Systems and methods for breaching a sterile field for intravascular placement of a catheter
CN103750858B (zh) 2007-11-26 2017-04-12 C·R·巴德股份有限公司 用于脉管系统内的导管放置的集成系统
US10449330B2 (en) 2007-11-26 2019-10-22 C. R. Bard, Inc. Magnetic element-equipped needle assemblies
US10751509B2 (en) 2007-11-26 2020-08-25 C. R. Bard, Inc. Iconic representations for guidance of an indwelling medical device
EP2065046B1 (de) 2007-11-30 2013-07-31 Kao Corporation GIP-Sekretionshemmer
CN101485440B (zh) * 2008-01-18 2012-12-26 张清 一种离子释放型凝胶化的解酒和抑制食物成分吸收的方法和制品
US8478382B2 (en) 2008-02-11 2013-07-02 C. R. Bard, Inc. Systems and methods for positioning a catheter
US9901714B2 (en) 2008-08-22 2018-02-27 C. R. Bard, Inc. Catheter assembly including ECG sensor and magnetic assemblies
US8437833B2 (en) 2008-10-07 2013-05-07 Bard Access Systems, Inc. Percutaneous magnetic gastrostomy
WO2010116210A1 (en) * 2009-04-10 2010-10-14 Compagnie Gervais Danone Acidic beverage containing low-methoxyl amidated pectin and no added calcium for a satiety effect
US9532724B2 (en) 2009-06-12 2017-01-03 Bard Access Systems, Inc. Apparatus and method for catheter navigation using endovascular energy mapping
US9445734B2 (en) 2009-06-12 2016-09-20 Bard Access Systems, Inc. Devices and methods for endovascular electrography
CN102802514B (zh) 2009-06-12 2015-12-02 巴德阿克塞斯系统股份有限公司 导管末端定位设备
US8338389B2 (en) 2009-06-17 2012-12-25 Kao Corporation Agent for preventing or ameliorating obesity
EP2482719A4 (de) 2009-09-29 2016-03-09 Bard Inc C R Dornen zur verwendung in einer vorrichtung zur intravaskulären positionierung eines katheters
US11103213B2 (en) 2009-10-08 2021-08-31 C. R. Bard, Inc. Spacers for use with an ultrasound probe
EP3461473B1 (de) * 2009-12-18 2021-09-22 Kaneka Corporation Flüssige lebensmittelzusammensetzung, welche halbverfestigt ist im sauren bereich
CN102821679B (zh) 2010-02-02 2016-04-27 C·R·巴德股份有限公司 用于导管导航和末端定位的装置和方法
KR101827026B1 (ko) 2010-04-29 2018-02-07 다우 글로벌 테크놀로지스 엘엘씨 포만감을 유도하는 방법 및 조성물
ES2778041T3 (es) 2010-05-28 2020-08-07 Bard Inc C R Aparato para su uso con sistema de guiado de inserción de aguja
CA2806353A1 (en) 2010-08-09 2012-02-16 C.R. Bard Inc. Support and cover structures for an ultrasound probe head
US20120046562A1 (en) 2010-08-20 2012-02-23 C. R. Bard, Inc. Reconfirmation of ecg-assisted catheter tip placement
EP2632360A4 (de) 2010-10-29 2014-05-21 Bard Inc C R Bioimpedanz-gestützte platzierung einer medizinischen vorrichtung
CA2835890A1 (en) 2011-07-06 2013-01-10 C.R. Bard, Inc. Needle length determination and calibration for insertion guidance system
CN102871117A (zh) * 2011-07-15 2013-01-16 张清 一种控制食物成分吸收的方法及其制品
USD699359S1 (en) 2011-08-09 2014-02-11 C. R. Bard, Inc. Ultrasound probe head
USD724745S1 (en) 2011-08-09 2015-03-17 C. R. Bard, Inc. Cap for an ultrasound probe
WO2013070775A1 (en) 2011-11-07 2013-05-16 C.R. Bard, Inc Ruggedized ultrasound hydrogel insert
TW201402017A (zh) * 2012-04-04 2014-01-16 大正製藥股份有限公司 水性液體飲料
EP2861153A4 (de) 2012-06-15 2016-10-19 Bard Inc C R Vorrichtung und verfahren zum nachweis einer abnehmbaren kappe auf einer ultraschallsonde
WO2014032676A1 (en) * 2012-09-03 2014-03-06 S-Biotek Holding Aps A solid oral formulation for treatment and/or prevention of overweight and/or for stabilizing blood sugar levels in an individual.
CN104853622B (zh) * 2012-12-25 2020-10-27 大正制药株式会社 水性碳酸饮料
WO2014200079A1 (ja) 2013-06-14 2014-12-18 株式会社カネカ 液状食品組成物の製造方法
WO2015120256A2 (en) 2014-02-06 2015-08-13 C.R. Bard, Inc. Systems and methods for guidance and placement of an intravascular device
KR102514110B1 (ko) 2014-05-05 2023-03-24 어드밴스드 메디칼 솔루션스 이스라엘 (실란티스) 엘티디. 생물학적 접착제 및 밀봉제, 그리고 이들을 이용하는 방법
US10973584B2 (en) 2015-01-19 2021-04-13 Bard Access Systems, Inc. Device and method for vascular access
US10349890B2 (en) 2015-06-26 2019-07-16 C. R. Bard, Inc. Connector interface for ECG-based catheter positioning system
CN105601956B (zh) * 2015-12-01 2018-09-28 大连工业大学 一种Iota-卡拉胶凝胶及其制备方法
US11000207B2 (en) 2016-01-29 2021-05-11 C. R. Bard, Inc. Multiple coil system for tracking a medical device
RU2739601C2 (ru) 2016-04-29 2020-12-28 Ламинария Груп Аб Питательная добавка
WO2017186948A1 (en) 2016-04-29 2017-11-02 Laminaria Group Ab Nutritional supplements
CN108451973A (zh) * 2018-01-30 2018-08-28 无锡福尔顺科技有限公司 一种消化道凝胶保护剂及其使用方法和应用
US11110118B2 (en) 2018-03-02 2021-09-07 Pharagen Llc Formulations for treating acid reflux comprising sodium alginate
CA3095096A1 (en) 2018-03-27 2019-10-03 Laminaria Group Ab Nutritional supplements
CN112867443B (zh) 2018-10-16 2024-04-26 巴德阿克塞斯系统股份有限公司 用于建立电连接的安全装备连接系统及其方法
US12544101B2 (en) 2019-01-30 2026-02-10 Bard Access Systems, Inc. Systems and methods for tracking medical devices
FR3109300B1 (fr) * 2020-04-21 2022-11-25 Centaur Clinical Cro Composition d’hydrogel assimilable par voie orale, kit et utilisation
FR3119516B1 (fr) * 2021-02-09 2023-01-13 Sonjal Procédé de préparation d’un gel d’enrobage de mêlée de saucisse comprenant un traitement à haute pression
CN117462767A (zh) * 2023-11-01 2024-01-30 江苏集萃功能材料研究所有限公司 胃部填充用可注射水凝胶及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2935409A (en) * 1956-11-12 1960-05-03 Alginate Ind Ltd Powdered alginate jelly composition and method of preparing the same
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
JP2673992B2 (ja) * 1990-05-17 1997-11-05 明治製菓株式会社 食品用組成物
EP0758529B1 (de) * 1995-08-11 2001-04-18 Societe Des Produits Nestle S.A. Verfahren zur Nahrungsmittelumstrukturierung mit Kontrolle des Gelierens
US20010007673A1 (en) * 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
US6187367B1 (en) * 1997-09-25 2001-02-13 Protein Technologies International, Inc. Low viscosity meat emulsion and process for producing a protein composition useful to form a low viscosity meat emulsion
GB9910212D0 (en) * 1999-05-05 1999-06-30 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
DK1395133T3 (da) * 2001-05-31 2006-08-21 Abbott Lab Af polymer kontrolleret system af fibre med fremkaldt viskositet og anvendelser deraf
JP2003079325A (ja) * 2001-06-28 2003-03-18 Kanebo Ltd ゲル化粉末
US6989166B2 (en) * 2001-12-20 2006-01-24 N.V. Nutricia Soft drink replacer
US6884445B2 (en) * 2001-12-20 2005-04-26 N.V. Nutricia Matrix-forming composition containing pectin
CN100348617C (zh) * 2001-12-21 2007-11-14 拜尔作物科学有限责任公司 预胶凝化淀粉和它们的生产方法
ITMI20022358A1 (it) * 2002-11-07 2004-05-08 Bsd Bioscience Dev Snc Composizioni farmaceutiche effervescenti per la realizzazione di sospensioni non convenzionali.
AU2003304197A1 (en) * 2003-06-18 2005-01-04 N.V. Nutricia Hot liquid fiber product
EP1663326B1 (de) * 2003-09-08 2010-03-03 FMC Biopolymer AS Gel-schaum auf biopolymer-basis

Also Published As

Publication number Publication date
CN101631476B (zh) 2012-07-04
JP5541865B2 (ja) 2014-07-09
PL1931222T3 (pl) 2012-07-31
CN101631476A (zh) 2010-01-20
US20070087038A1 (en) 2007-04-19
EP1931222A2 (de) 2008-06-18
WO2007039294A2 (en) 2007-04-12
ES2379723T3 (es) 2012-05-03
WO2007039294A3 (en) 2007-06-14
EP1931222B1 (de) 2012-02-15
JP2009524575A (ja) 2009-07-02

Similar Documents

Publication Publication Date Title
PL1931222T3 (pl) Żelujące kompozycje i sposoby
MX2009000722A (es) Composiciones liquidas de acetato de calcio.
WO2014152796A3 (en) Biocompatible and bioabsorbable derivatized chitosan compositions
WO2008157635A3 (en) Synthetic bile acid composition, method, and preparation
PL1992361T3 (pl) Środek do leczenia lub zapobiegania wrzodowi trawiennemu
EA201592055A1 (ru) 11-гидроксилпроизводные желчных кислот и их аминокислотные конъюгаты в качестве модуляторов фарнезоидных х-рецепторов
WO2008015374A3 (en) Protein free formula
BR112012015541A8 (pt) Composições minerais organicamente quelada e métodos de seus usos
EP4218819A3 (de) Kombinationstherapie auf der basis von pd-1-signalhemmern
CL2019002678A1 (es) Composición adhesiva y método para preparar la misma.
BRPI0807982A8 (pt) Produto dietético compreendendo alginato
ES2851226T3 (es) Bebida carbonatada a base de agua
WO2009034315A3 (en) Vaccine
WO2006127593A3 (en) Restrictive and/or obstructive implant system for inducing weight loss
BR112015032370A2 (pt) derivados de biarila, composição, e, método para preparar uma composição
WO2007092343A3 (en) Novel epoprostenol formulation and method of making thereof
MX2011007301A (es) Dabigatran liofilizado.
BR112018008040A2 (pt) composição nutricional compreendendo um hidrolisado de caseína, bem como um butirato dietético e/ou um composto para estimular a formação de butirato endógeno
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
MX2009012782A (es) Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados.
WO2010035122A3 (fr) Complexe constitue d'un polysaccharide et d'une hpb
UY36569A (es) Composiciones para uso en el tratamiento de diarrea y en la promoción de la salud intestinal en animales no humanos
US8993539B2 (en) Dietary fiber supplements for appetite suppression
PL422220A1 (pl) Kompozycja farmaceutyczna w postaci wodnego roztworu, korzystnie syropu, zawierająca pranobeks inozyny oraz glukonianu cynku oraz jej sposób otrzymywania
WO2007075255B1 (en) Mastic gum composition for use as a dietary supplement in humans and animals